Skip to Main Content

Paper Details

Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEK.
Mol Cancer Ther
13
2021
Author NameAffiliation
Alex BoussioutasPeter MacCallum Cancer Centre
Alex BoussioutasUniversity of Melbourne
Alex BoussioutasPeter MacCallum Cancer Centre
Alex BoussioutasUniversity of Melbourne
John M MariadasonOlivia Newton-John Cancer Research Institute
John M MariadasonLa Trobe University
John M MariadasonSt. George Hospital
  • 1 - 7

Datasets

Release 1.2